| Kathleen L Schomer, DO | |
|
1343 N Fountain Blvd, Springfield, OH 45504-1422 | |
| (937) 390-5000 | |
| (937) 390-5526 |
| Full Name | Kathleen L Schomer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 1343 N Fountain Blvd, Springfield, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124070685 | NPI | - | NPPES |
| 2307373 | Medicaid | OH | |
| P00117444 | Other | RAIL ROAD MEDICARE | |
| 000000319324 | Other | OH | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 34007651S (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Galion Community Hospital | Galion, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Central Ohio Family Care Center Inc | 3274437082 | 179 |
News Archive
New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.
ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.
Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.
› Verified 7 days ago
| Entity Name | North Central Ohio Family Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689822827 PECOS PAC ID: 3274437082 Enrollment ID: O20031124000232 |
News Archive
New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.
ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.
Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.
› Verified 7 days ago
| Entity Name | Ohio Emergency Professionals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982983425 PECOS PAC ID: 0547433328 Enrollment ID: O20111024000785 |
News Archive
New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.
ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.
Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.
› Verified 7 days ago
| Entity Name | Ohio Emergency Care Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184028524 PECOS PAC ID: 1658695424 Enrollment ID: O20150127000965 |
News Archive
New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.
ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.
Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen L Schomer, DO 4750 Hempstead Station Dr, Kettering, OH 45429-5164 Ph: (800) 875-0136 | Kathleen L Schomer, DO 1343 N Fountain Blvd, Springfield, OH 45504-1422 Ph: (937) 390-5000 |
News Archive
New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.
ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.
Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.
› Verified 7 days ago
Wade G Smith, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1343 N Fountain Blvd, Springfield, OH 45504 Phone: 937-390-5000 Fax: 937-390-5526 | |
Chidoziri C. Nwokoro, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Medical Center Dr, Springfield, OH 45504 Phone: 937-523-1000 | |
James Bianchi Iii, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2615 E High St, Springfield, OH 45505 Phone: 937-325-0531 | |
Ashli Burns, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Department Of Emergency Medicine, Springfield, OH 45504 Phone: 614-293-3551 | |
Dr. Annette Raquel Nathan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Medical Center Way, Springfield Regional Medical Center, Springfield, OH 45505 Phone: 937-523-1401 Fax: 937-523-1950 | |
Dr. Bethany Paczkowski, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Medical Center Dr, Springfield, OH 45504 Phone: 937-523-5062 |